A detailed history of Inspire Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Inspire Advisors, LLC holds 1,624 shares of ABBV stock, worth $287,366. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,624
Previous 1,537 5.66%
Holding current value
$287,366
Previous $263,000 21.67%
% of portfolio
0.04%
Previous 0.04%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$163.84 - $199.33 $14,254 - $17,341
87 Added 5.66%
1,624 $320,000
Q2 2024

Aug 08, 2024

BUY
$154.79 - $180.76 $9,442 - $11,026
61 Added 4.13%
1,537 $263,000
Q1 2024

May 07, 2024

SELL
$159.82 - $182.1 $15,502 - $17,663
-97 Reduced 6.17%
1,476 $268,000
Q4 2023

Feb 12, 2024

BUY
$137.6 - $154.97 $216,444 - $243,767
1,573 New
1,573 $243,000
Q1 2021

Apr 30, 2021

SELL
$102.3 - $112.62 $6,751 - $7,432
-66 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $5,312 - $7,172
66 New
66 $7,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Inspire Advisors, LLC Portfolio

Follow Inspire Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inspire Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inspire Advisors, LLC with notifications on news.